These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 30941722

  • 1. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®.
    Syk J, Vinge I, Sörberg M, Vahteristo M, Rytilä P.
    Adv Ther; 2019 Jul; 36(7):1756-1769. PubMed ID: 30941722
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler® Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes.
    Gálffy G, Szilasi M, Tamási L.
    Pulm Ther; 2019 Dec; 5(2):165-177. PubMed ID: 32026408
    [Abstract] [Full Text] [Related]

  • 3. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler® for Patients with Poorly Controlled Obstructive Airway Disease: a Real-World Study of Patient-Reported Outcomes.
    Tamási L, Szilasi M, Gálffy G.
    Adv Ther; 2018 Aug; 35(8):1140-1152. PubMed ID: 30066185
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S, Vahteristo M, Metev H, Taseva M, Stamatova N, Bartha A, Schlezák J, Sairanen U.
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [Abstract] [Full Text] [Related]

  • 9. Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®.
    Lewis A, Torvinen S, Dekhuijzen PNR, Chrystyn H, Melani A, Zöllner Y, Kolbe K, Watson AT, Blackney M, Plich A.
    Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 Aug; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®).
    Malmberg LP, Everard ML, Haikarainen J, Lähelmä S.
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):329-40. PubMed ID: 24978441
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD.
    Gálffy G, Mezei G, Németh G, Tamási L, Müller V, Selroos O, Orosz M.
    Drugs R D; 2013 Sep; 13(3):215-22. PubMed ID: 24043456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.